Dear Valued Customer,

The COVID-19 situation continues to be dynamic, and circumstances are changing frequently. We recognize that ensuring a secure supply of materials is extremely important for you, and even more critical during a global crisis such as COVID-19. As a global life sciences business, we are committed to do our utmost to ensure a secure supply to our customers in all parts of the world.

First and foremost, we take the health, safety, and security of our global colleagues, customers and supply partners very seriously. Since the news was first reported, we convened a dedicated multi-functional team to coordinate our response. This team continues to be in contact with the Centers for Disease Control and Prevention (CDC) and seeks guidance from the World Health Organization (WHO) and other global health organizations.

The global pandemic has brought a significant increase in unforecast demand. While we continue to manufacture to our expected annual production schedule, and additional capacity has come online as part of our investment programs globally, we are seeing demand pressures in some areas. Your account managers will be in touch personally if you are affected.

We encourage all customers to review their forecast and lead times with their Cytiva account management team to assist us in our production planning to produce the materials that you need.

Manufacturing / raw materials

We are monitoring factory capacity closely, and this remains largely unaffected. Supply of raw materials is another key topic. We are in continuous communication with our supply partners in “lock-down” locations to ensure security of supply, and we are providing assistance and support where necessary. Where prudent we are working with suppliers to secure an appropriate level of safety stock for key raw materials.

Demand across the entire portfolio remains high with a significant increase in unforecasted orders. Incoming demand and operational planning is done weekly to flex manufacturing capability to reflect the changing need.

This dynamic situation affects different product portfolios in different ways. Please visit our FAQ page and/or contact your local account management team for further information.

Business continuity management

We regularly adjust our manufacturing output to respond to market demands, while ensuring our plants can continue with safe operations. At this time, the Crisis Management teams at all Cytiva plants have been activated and a Cytiva crisis team is in place to monitor the situation on a daily basis. We are taking necessary actions to secure the health and safety of all personnel working on our manufacturing sites, while ensuring that we can keep the manufacturing operations running.

Fulfillment and logistics

Logistics and the movement of goods during the COVID-19 situation has been and remains dynamic, however the overall global logistics capacity has stabilized with an increase in air cargo capacity over recent weeks.

Our fulfilment and logistics teams, through close daily connection with our distribution partners, have been able to maintain the movement of goods globally. Overall, we are currently experiencing an additional transit time globally of 3-4 days above our standard delivery times.

Thank you for your patience during this challenging time. We appreciate your business and we will continue to work closely in our team to help ensure that, wherever reasonably possible, our supplies to you are maintained. We will continue to update you as the situation evolves.

Please visit our COVID-19 FAQ page or approach your local account manager for additional information.


Emmanuel Ligner
President and CEO